Regionshospitalet Horsens
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Regionshospitalet Horsens investigators are testing a rapid‑acting chemical to improve outcomes after sudden heart failure, aiming to boost the chance of restoring a normal heartbeat.
- Evaluation of sodium bicarbonate during emergency resuscitation
- Measurement of return of spontaneous circulation rates
- Development of optimized in‑hospital cardiac arrest protocols
The work supports the hospital’s commitment to advancing acute cardiac care and may influence future guidelines for emergency medicine.
Musculoskeletal Diseases
Researchers are comparing two minimally invasive approaches for a common hand condition, seeking a treatment that lowers the likelihood of the finger bending again.
- Use of Percutaneous Needle Fasciotomy combined with corticosteroid injection
- Comparison with saline injection as a control
- Assessment of long‑term joint extension and recurrence rates
This trial reflects the department’s focus on improving functional outcomes for patients with Dupuytren Contracture.
Skin and Connective Tissue Diseases
While current studies target heart and hand disorders, the orthopedic team also investigates how needle‑based procedures affect fibrotic tissue, a key factor in many skin and connective‑tissue conditions.
- Analysis of fibrotic tissue remodeling after needle intervention
- Exploration of adjunct pharmacologic injections to modulate scar formation
- Integration of minimally invasive techniques with connective‑tissue healing research
These efforts broaden the site’s expertise in treating disorders that involve abnormal tissue growth and repair.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Region Midtjylland1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Region Midtjylland2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Regionshospitalet Horsens
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Bicarbonate for In-Hospital Cardiac Arrest – A Randomized, Double-Blind, Placebo-Controlled Trial | Region Midtjylland | Phase III | Not Recruiting | Feb 2023 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anhydrous Lidocaine Hydrochloride | 1 | Unknown | 2023-01-10 | 2023-01-10 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.